yttrium radioisotopes has been researched along with African Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banz, Y; Klaeser, B; Koechli, V; Mueller, BU; Pabst, T | 1 |
| Chang, CH; Goldenberg, DM; Johnson, CR; Karacay, H; Litwin, S; McBride, WJ; Rossi, EA; Sharkey, RM | 1 |
| Brechbiel, MW; Burns, LJ; Dusenbery, KE; Elson, M; Jaszcz, WB; Kersey, JH; Kuroki, DW; Panoskaltsis-Mortari, A; Ramsay, NK; Skubitz, KM; Vallera, DA; Wagner, JE | 1 |
| Brechbiel, MW; Burns, LJ; Dusenbery, KE; Elson, M; Jaszcz, WB; Kersey, JH; Kuroki, DW; Panoskaltsis-Mortar, A; Ramsay, NK; Vallera, DA; Vitetta, ES; Wagner, JE | 1 |
| DeNardo, GL; DeNardo, SJ; Kroger, LA; Kukis, DL; Miers, LA; Mirick, GR; O'Donnell, RT | 1 |
| Barendswaard, E; Brechbiel, MW; Curcio, MJ; Lai, L; Ma, D; McDevitt, MR; Pellegrini, V; Scheinberg, DA | 1 |
1 trial(s) available for yttrium radioisotopes and African Lymphoma
| Article | Year |
|---|---|
Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Burkitt Lymphoma; Case-Control Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radioimmunotherapy; Remission Induction; Retrospective Studies; Survival Rate; Young Adult; Yttrium Radioisotopes | 2015 |
5 other study(ies) available for yttrium radioisotopes and African Lymphoma
| Article | Year |
|---|---|
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Burkitt Lymphoma; Drug Therapy, Combination; Histocompatibility Antigens Class II; Humans; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radiopharmaceuticals; Sialic Acid Binding Ig-like Lectin 2; Transplantation, Heterologous; Yttrium Radioisotopes | 2009 |
Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.
Topics: Animals; Antibodies, Monoclonal; Burkitt Lymphoma; Drug Evaluation, Preclinical; Female; Hematopoietic Stem Cells; Humans; Indium Radioisotopes; Leukemia, Myeloid; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 2003 |
Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antigens, CD19; Burkitt Lymphoma; Cell Line, Tumor; Humans; Indium Radioisotopes; Mice; Mice, Nude; Protein Binding; Radioimmunotherapy; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes | 2004 |
Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts.
Topics: Animals; Antibodies, Monoclonal; Burkitt Lymphoma; Combined Modality Therapy; Female; Humans; Mice; Mice, Nude; Paclitaxel; Radioimmunotherapy; Radiopharmaceuticals; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1998 |
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antigens, CD19; Antigens, CD20; Antigens, Neoplasm; Burkitt Lymphoma; Female; Humans; Mice; Mice, Nude; Radioimmunotherapy; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2002 |